Allovir Inc (ALVR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 7,774 | 32,299 | 62,405 | 46,961 | 47,304 |
Operating Income | -7,774 | -32,299 | -62,405 | -46,961 | -47,304 |
Other Income | 1,698 | 2,000 | 2,583 | 2,689 | 2,037 |
Pre-tax Income | -6,076 | -30,299 | -59,822 | -44,272 | -45,267 |
Net Income Continuous | -6,076 | -30,299 | -59,696 | -44,272 | -45,267 |
Net Income | $-6,076 | $-30,299 | $-59,696 | $-44,272 | $-45,267 |
EPS Basic Total Ops | -0.05 | -0.26 | -0.52 | -0.39 | -0.48 |
EPS Basic Continuous Ops | -0.05 | -0.26 | -0.52 | -0.39 | -0.48 |
EPS Diluted Total Ops | -0.05 | -0.26 | -0.52 | -0.39 | -0.48 |
EPS Diluted Continuous Ops | -0.05 | -0.26 | -0.52 | -0.39 | -0.48 |
EPS Diluted Before Non-Recurring Items | -0.05 | -0.18 | -0.53 | -0.39 | -0.48 |
EBITDA(a) | $-7,774 | $-32,299 | $-62,264 | $-46,875 | $-47,219 |